Received Jan 9, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| UNK | VACCINE NOT SPECIFIED (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | Y009094 | — |
The patient reported in this case did not report any adverse issues or side effects related to the administered dose of VAQTA; an expired adult dose of VAQTA (1mL) was inadvertently administered to two patients less than 18 years of age who should have received a pediatric dose of VAQTA (0.5mL) on 12/29/2025.; an expired adult dose of VAQTA (1mL) was inadvertently administered to two patients less than 18 years of age who should have received a pediatric dose of VAQTA (0.5mL) on 12/29/2025.; This spontaneous report was received from an Other health professional (Certificate Medical Assistant [C.M.A.]) and refers to a 16-year-old female patient. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 29-Dec-2025, the patient was inadvertently vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) Suspension for injection (pre-filled syringe) (valid lot #Y009094, expiration date: 29-Nov-2025) at dose 1 mL, once (strength: 50/1.0 U/ml) for prophylaxis (route of administration, anatomical location, dose number were not provided) to patient less than 18 years of age who should had received a pediatric dose of Hepatitis A Vaccine, Inactivated (VAQTA) (0.5mL) (Accidental overdose, Expired product administered). The patient did not report any adverse issues or side effects related to the administered dose of Hepatitis A Vaccine, Inactivated (VAQTA) and the product had never undergone any temperature excursions (no adverse event). This is one of two reports received from the same reported (case # 2366232).